» Articles » PMID: 23670710

How Does Antiretroviral Treatment Attenuate the Stigma of HIV? Evidence from a Cohort Study in Rural Uganda

Overview
Journal AIDS Behav
Date 2013 May 15
PMID 23670710
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Program implementers and qualitative researchers have described how increasing availability of HIV antiretroviral therapy (ART) is associated with improvements in psychosocial health and internalized stigma. To determine whether, and through what channels, ART reduces internalized stigma, we analyzed data from 262 HIV-infected, treatment-naïve persons in rural Uganda followed from ART initiation over a median of 3.4 years. We fitted Poisson regression models with cluster-correlated robust estimates of variance, specifying internalized stigma as the dependent variable, adjusting for time on treatment as well as socio-demographic, clinical, and psychosocial variables. Over time on treatment, internalized stigma declined steadily, with the largest decline observed during the first 2 years of treatment. This trend remained statistically significant after multivariable adjustment (χ(2) = 28.3; P = 0.03), and appeared to be driven by ART-induced improvements in HIV symptom burden, physical and psychological wellbeing, and depression symptom severity.

Citing Articles

The association of HIV status and depressive symptoms in the Ndlovu Cohort study.

den Boer L, Scheuermaier K, Tempelman H, Barth R, Deville W, Coutinho R Sci Rep. 2025; 15(1):4539.

PMID: 39915535 PMC: 11803091. DOI: 10.1038/s41598-025-85830-5.


Effective Messages to Reduce Stigma among People Newly Diagnosed with HIV during Rapid ART Initiation.

Campbell C, Koester K, Erguera X, Moran L, LeTourneau N, Broussard J Int J Environ Res Public Health. 2024; 21(9).

PMID: 39338016 PMC: 11431257. DOI: 10.3390/ijerph21091133.


Adherence to antiretroviral therapy among cisgender gay, bisexual and other men who have sex with men in Brazil: Evaluating the role of HIV-related stigma dimensions.

Matos V, Torres T, Luz P PLoS One. 2024; 19(8):e0308443.

PMID: 39116156 PMC: 11309385. DOI: 10.1371/journal.pone.0308443.


" Challenges to Antiretroviral Therapy Adherence in Kampala, Uganda.

Bruser G, Luginaah I, Katasi R, Zhang L, Namasinga M, Kityo C Afr Geogr Rev. 2024; 43(1):18-31.

PMID: 38576439 PMC: 10989837. DOI: 10.1080/19376812.2022.2101496.


Association Between Clinical Encounter Frequency and HIV-Related Stigma Among Newly-Diagnosed People Living with HIV in Rwanda.

Hill S, Zhang C, Remera E, Ingabire C, Umwiza F, Munyaneza A AIDS Behav. 2023; 28(4):1390-1400.

PMID: 38112826 PMC: 10947825. DOI: 10.1007/s10461-023-04226-6.


References
1.
Pearson C, Micek M, Pfeiffer J, Montoya P, Matediane E, Jonasse T . One year after ART initiation: psychosocial factors associated with stigma among HIV-positive Mozambicans. AIDS Behav. 2009; 13(6):1189-96. PMC: 2901423. DOI: 10.1007/s10461-009-9596-0. View

2.
Sengupta S, Banks B, Jonas D, Miles M, Smith G . HIV interventions to reduce HIV/AIDS stigma: a systematic review. AIDS Behav. 2010; 15(6):1075-87. PMC: 3128169. DOI: 10.1007/s10461-010-9847-0. View

3.
Farmer P, Leandre F, Mukherjee J, Claude M, Nevil P, Smith-Fawzi M . Community-based approaches to HIV treatment in resource-poor settings. Lancet. 2001; 358(9279):404-9. DOI: 10.1016/s0140-6736(01)05550-7. View

4.
Munoz M, Finnegan K, Zeladita J, Caldas A, Sanchez E, Callacna M . Community-based DOT-HAART accompaniment in an urban resource-poor setting. AIDS Behav. 2009; 14(3):721-30. PMC: 8327366. DOI: 10.1007/s10461-009-9559-5. View

5.
Khandelwal S, Avode G, Baingana F, Conde B, Cruz M, Deva P . Mental and neurological health research priorities setting in developing countries. Soc Psychiatry Psychiatr Epidemiol. 2009; 45(4):487-95. DOI: 10.1007/s00127-009-0089-2. View